{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:47:26Z","timestamp":1778874446839,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T00:00:00Z","timestamp":1535155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007279","name":"Shanghai Municipal Health Bureau","doi-asserted-by":"publisher","award":["2013ZYJB0902"],"award-info":[{"award-number":["2013ZYJB0902"]}],"id":[{"id":"10.13039\/501100007279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007279","name":"Shanghai Municipal Health Bureau","doi-asserted-by":"publisher","award":["15GWZK1002"],"award-info":[{"award-number":["15GWZK1002"]}],"id":[{"id":"10.13039\/501100007279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670377"],"award-info":[{"award-number":["81670377"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12944-018-0800-y","type":"journal-article","created":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T08:28:05Z","timestamp":1535185685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Comparison of various lipid parameters in association of target organ damage: a cohort study"],"prefix":"10.1186","volume":"17","author":[{"given":"Chen","family":"Chi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiadela","family":"Teliewubai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-Min","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Kai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Wu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Wei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8693-3554","authenticated-orcid":false,"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,25]]},"reference":[{"key":"800_CR1","unstructured":"National Institute for Health and Care Excellence Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. NICE guidelines [CG181]. http:\/\/www.nice.org.uk\/Guidance\/CG181 . Accessed 15 June 2017."},{"key":"800_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jacl.2013.10.001","volume":"7","author":"SM Grundy","year":"2013","unstructured":"Grundy SM, Arai H, Barter PJ, Bersot TP, Betteridge DJ, Carmena R, et al. An international atherosclerosis society position paper: global recommendations for the management of dyslipidemia. J Clin Lipidol. 2013;7:29\u201360.","journal-title":"J Clin Lipidol."},{"key":"800_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jacl.2015.02.003","volume":"9","author":"TA Jacobson","year":"2015","unstructured":"Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH, et al. National Lipid Association Recommendations for patient-centered Management of Dyslipidemia: part 1\u2014full report. J Clin Lipidol. 2015;9:129\u201369.","journal-title":"J Clin Lipidol"},{"key":"800_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2016.08.018","volume":"253","author":"AL Catapano","year":"2016","unstructured":"Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC\/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 2016;253:281\u2013344.","journal-title":"Atherosclerosis"},{"key":"800_CR5","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S0140-6736(14)61217-4","volume":"384","author":"DJ Rader","year":"2014","unstructured":"Rader DJ, Hovingh GK. HDL and cardiovascular disease. Lancet. 2014;384:618\u201325.","journal-title":"Lancet"},{"key":"800_CR6","first-page":"2499","volume":"307","author":"ED Angelantonio","year":"2012","unstructured":"Angelantonio ED, Gao P, Pennells L, Kaptoge S, Caslake MJ, Thompson A, et al. Lipid-related markers and cardiovascular disease prediction. JAMA. 2012;307:2499\u2013506.","journal-title":"JAMA"},{"key":"800_CR7","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1001\/jama.2012.366","volume":"307","author":"SM Boekholdt","year":"2012","unstructured":"Boekholdt SM, Arsenault BJ, Mora S, Pedersen TR, LaRosa JC, Nestel PJ, et al. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. JAMA. 2012;307:1302\u20139.","journal-title":"JAMA"},{"key":"800_CR8","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH\/ESC Guidelines for the management of arterial hypertension. Eur Heart J. 2013;34:2159\u2013219.","journal-title":"Eur Heart J"},{"key":"800_CR9","doi-asserted-by":"publisher","unstructured":"Ji H, Xiong J, Yu S, Chi C, Fan X, Bai B, et al. Northern shanghai study: cardiovascular risk and its associated factors in the Chinese elderly-a study protocol of a prospective study design. BMJ Open. 2017; https:\/\/doi.org\/10.1136\/bmjopen-2016-013880 .","DOI":"10.1136\/bmjopen-2016-013880"},{"key":"800_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/HJH.0b013e32834fa8b0","volume":"30","author":"LM Van Bortel","year":"2012","unstructured":"Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank K, De Backer T, et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens. 2012;30:445\u20138.","journal-title":"J Hypertens"},{"key":"800_CR11","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/clinchem\/28.6.1379","volume":"28","author":"GR Warnick","year":"1982","unstructured":"Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982;28:1379\u201388.","journal-title":"Clin Chem"},{"key":"800_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0009-8981(87)90188-4","volume":"166","author":"JR Mcnamara","year":"1987","unstructured":"Mcnamara JR, Schaefer EJ. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta. 1987;166:1\u20138.","journal-title":"Clin Chim Acta"},{"key":"800_CR13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499\u2013502.","journal-title":"Clin Chem"},{"key":"800_CR14","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1681\/ASN.2006040368","volume":"17","author":"Y Ma","year":"2006","unstructured":"Ma Y, Zuo L, Chen J, Luo Q, Yu X, Li Y, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2937\u201344.","journal-title":"J Am Soc Nephrol"},{"key":"800_CR15","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/00041433-200012000-00008","volume":"11","author":"RJ Havel","year":"2000","unstructured":"Havel RJ. Remnant lipoproteins as therapeutic targets. Curr Opin Lipidol. 2000;11:615\u201320.","journal-title":"Curr Opin Lipidol"},{"key":"800_CR16","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","volume":"61","author":"A Varbo","year":"2013","unstructured":"Varbo A, Benn M, Tybjaerghansen A, Jorgensen A, Frikkeschmidt R, Nordestgaard BG. Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol. 2013;61:427\u201336.","journal-title":"J Am Coll Cardiol"},{"key":"800_CR17","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.amjcard.2005.06.044","volume":"96","author":"WR Farwell","year":"2005","unstructured":"Farwell WR, Sesso HD, Buring JE, Gaziano JM. Non\u2013high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol as a risk factor for a first nonfatal myocardial infarction. Am J Cardiol. 2005;96:1129\u201334.","journal-title":"Am J Cardiol"},{"key":"800_CR18","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.amjcard.2006.06.032","volume":"98","author":"J Liu","year":"2006","unstructured":"Liu J, Sempos CT, Donahue RP, Dorn J, Trevisan M, Grundy SM. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. Am J Cardiol. 2006;98:1363\u20138.","journal-title":"Am J Cardiol"},{"key":"800_CR19","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1172\/JCI10695","volume":"106","author":"MM Veniant","year":"2000","unstructured":"Veniant MM, Sullivan M, Kim SK, Ambroziak P, Chu A, Wilson MD, et al. Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100. J Clin Invest. 2000;106:1501\u201310.","journal-title":"J Clin Invest"},{"key":"800_CR20","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/0002-8703(91)90694-D","volume":"121","author":"VJ Dzau","year":"1991","unstructured":"Dzau VJ, Braunwald E. Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement. Am Heart J. 1991;121:1244\u201363.","journal-title":"Am Heart J"},{"key":"800_CR21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/0002-9149(92)91083-G","volume":"70","author":"WP Castelli","year":"1992","unstructured":"Castelli WP. Epidemiology of triglycerides: a view from Framingham. Am J Cardiol. 1992;70:292.","journal-title":"Am J Cardiol"},{"key":"800_CR22","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.2337\/diacare.27.8.1991","volume":"27","author":"R Jiang","year":"2004","unstructured":"Jiang R, Schulze MB, Li T, Rifai N, Stampfer MJ, Rimm EB, Hu FB. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes. Diabetes Care. 2004;27:1991\u20137.","journal-title":"Diabetes Care"},{"key":"800_CR23","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.2337\/dc11-1412","volume":"35","author":"H Sone","year":"2012","unstructured":"Sone H, Tanaka S, Tanaka S, Iimuro S, Ishibashi S, Oikawa S, et al. Comparison of various lipid variables as predictors of coronary heart disease in Japanese men and women with type 2 diabetes subanalysis of the Japan diabetes complications study. Diabetes Care. 2012;35:1150\u20137.","journal-title":"Diabetes Care"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0800-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-018-0800-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0800-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T07:42:32Z","timestamp":1604821352000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-018-0800-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,25]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["800"],"URL":"https:\/\/doi.org\/10.1186\/s12944-018-0800-y","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,25]]},"assertion":[{"value":"28 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study is approved by the Ethics Committee of Shanghai Tenth People\u2019s Hospital. All participants or their legal caregivers voluntarily signed the individual informed consents.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"199"}}